AKSO Biopharmaceutical is a global focused biopharmaceutical company dedicated to delivering groundbreaking therapeutics for patients with urgent unmet clinical needs in cancer, fibrosis …

Transforming the Future of Protein Therapeutics by harnessing the full potential of \u0003protein-protein interaction. We work to integrate our engineering strategies with a deep understanding …

Directed Evolution Enhancement Platform utilizes strategic marriage of knowledge between biochemical and structural information aiming at fully leveraging the natural component of any …

AKSO and Huadong Medicine Announce Strategic Collaboration to Develop and Commercialize AB002 in Asia Pacific Ex-Japan. February 19, 2022

Apr 19, 2021 · Dr. Zhang is the Co-Founder and Chief Executive Officer of AKSO Biopharmaceutical, Inc. He brings extensive expertise in corporate finance, strategic planning, …

AKSO Biopharmaceutical - 1801 Century Park East, Ste 1901, Los Angeles, CA 90067

Feb 19, 2022 · Huadong Medicine is granted from AKSO Biopharmaceutical an exclusive right to develop and commercialize AB002 in the Asia Pacific Ex-Japan region for solid tumors; AKSO …

Dr. Miao is co-founder and Chief Scientific Advisor of AKSO Biopharmaceutical Inc. Prior to founding AKSO Bio, Dr. Miao led the development effort of numerous therapeutic molecules …

Mr. Zhang is co‐founder and Chief Executive Officer of AKSO Biopharmaceutical Inc. Mr. Zhang brings a wealth of corporate finance, strategic and operation management experience to AKSO.

Dr. Giaccia is the Co-Founder, Senior Scientific Strategist, and Chairman of AKSO Biopharmaceutical, Inc. He currently serves as the Director of the Oxford Institute of Radiation …